Clinical Trial Update: Exenatide Treatment in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating exenatide treatment for Parkinson's disease is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Center for Neurology, Stockholm | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN